arrow_back Back to App

Biotechnology Safety: Risk Research and New Regulations

This Act aims to enhance the safety of biotechnology products, such as modified plants or medicines. Citizens can expect these products to be more thoroughly researched for their impact on health and the environment, ensuring greater safety in daily life. New research and guidelines will be introduced to better assess potential risks and benefits.
Key points
Support for research into the safety of biotechnology products to better understand their impact on human, animal, and environmental health.
Establishment of a funding program for research that will help create clear regulatory pathways for biotechnology products.
Conducting a two-phase study by the National Academies of Sciences, Engineering, and Medicine, assessing the safety and benefits of biotechnology.
Requirement to make research findings publicly available, increasing access to information for citizens and policymakers.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_2697
Sponsor: Sen. Young, Todd [R-IN]
Process start date: 2025-09-03
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

National Biotechnology Safety Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_2697.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-09-03.

What are the main provisions?

Key points include:

  • Support for research into the safety of biotechnology products to better understand their impact on human, animal, and environmental health.
  • Establishment of a funding program for research that will help create clear regulatory pathways for biotechnology products.
  • Conducting a two-phase study by the National Academies of Sciences, Engineering, and Medicine, assessing the safety and benefits of biotechnology.
  • Requirement to make research findings publicly available, increasing access to information for citizens and policymakers.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Young, Todd [R-IN].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health Environment Agriculture